Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Mobile App on Purpose and Well-Being Among College Students (PWB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03378505
Recruitment Status : Completed
First Posted : December 19, 2017
Last Update Posted : December 6, 2019
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison

Brief Summary:
This study will examine the impact of a mobile app (JOOL) focused on promoting purposeful living on student health behaviors, academic performance, self-regulation, well-being, resiliency, and self-efficacy.

Condition or disease Intervention/treatment Phase
Healthy Behavioral: Mobile App Behavioral: Reflection Not Applicable

Detailed Description:
Participants will be recruited from a large undergraduate classroom. Participants will be randomly assigned to one of two conditions and asked to complete either online reflections or engage with a mobile app over the course of the semester. Students who elect to not participate will be provided an alternate assignment to complete, to be coordinated by their teaching assistant. Participants will additionally be asked to complete (1) a pre-survey, (2) post-survey, and follow-up survey 14 days after the class concludes. The study will examine changes in health-related behaviors, resiliency, well-being, and self-efficacy reported between the start and conclusion of semester/study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 112 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants will be randomly assigned to two conditions. Half of the participants will be required to use a daily check-in mobile app that promotes alignment of daily behaviors with their individualized life purpose. The other half of participants will complete brief bi-weekly reflections. Alternative assignment provided for non-participating students.
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Living Purposefully: The Role of Mobile App JOOL in Promoting Well-being and Academic Success
Actual Study Start Date : January 24, 2018
Actual Primary Completion Date : May 21, 2018
Actual Study Completion Date : August 1, 2019

Arm Intervention/treatment
Experimental: Mobile App
Half of the students randomly assigned
Behavioral: Mobile App
Purposeful Living Mobile App JOOL to be used daily
Other Name: JOOL

Experimental: Reflection
Half of the students randomly assigned
Behavioral: Reflection
Bi-weekly online reflection question




Primary Outcome Measures :
  1. Change in Health Behaviors [ Time Frame: 14 weeks post start (1 semester) ]
    Expected increase in self-report of behaviors promoting academic achievement, physical health, well-being, and purpose from time of pre survey to post survey.

  2. Change in Resiliency [ Time Frame: 14 weeks post start (1 semester) ]
    Brief Resiliency Scale (BRS) used to measure resiliency, or ""the ability to bounce back or recover from stress" (Smith et al., 2008). 6 items using Likert scale strongly disagree (1) to strongly agree (5). Score will be summed for one total score and can range from 6 to 30, with 6 indicating low resilience and 30 indicating high resilience. No clinical cut off. Expected increase no change in scores from pre and post.

  3. Change in Self-Regulation [ Time Frame: 14 weeks post start (1 semester) ]
    Self-Regulation Scale (SRQ) short form used to measure self-regulation, or ""the ability to develop, implement, and flexibly maintain planned behavior in order to achieve one's goal" (Brown, Miller, & Lawendowski, 1999). 31 items using a Likert scale strongly disagree (1) to strongly agree (5), with 14 reverse coded. Scores will be summed for one total score ranging from 31 to 155. 31 indicates low self-regulation and 155 indicates high self-regulation. No clinical cut off. Expected increase or no change in scores from pre and post.

  4. Change in belief of ability to perform difficult tasks or cope with diversity [ Time Frame: 14 weeks post start (1 semester) ]
    Generalized Self-Efficacy Scale used to measure self-efficacy, or "the optimistic self-belief that one can perform novel or difficult tasks or cope with diversity" (Schwarzer, 1992). 10 items on a Likert scale from Not true at all (1) to Exactly true (4). Responses will be summed for one total score, ranging from 10 to 40. 10 indicates low self-efficacy, 40 indicates high self-efficacy. No clinical cut off. Expected increase or no change in scores from pre and post.

  5. Change in Well-Being [ Time Frame: 14 weeks post start (1 semester) ]
    The WHO (Five) Well-Being Index (WHO-5) measures well-being, defined as the subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in things). 5 items on a Likert scale ranging from all of the time (5) to at no time (1). Responses will be summed for one total score ranging from 0 to 25. 0 indicates low well-being and 5 indicates high well-being. Score below 13 indicates poor well-being. Expected increase or no change in scores from pre and post.


Secondary Outcome Measures :
  1. Change in Health Behaviors [ Time Frame: 14 days (2 weeks) after end of study (16 weeks post start) ]
    Expected increase or no change in reported health behaviors around academic achievement and well-being from time of post survey. To be completed 2 weeks after post-survey.

  2. App Perceptions [ Time Frame: 14 days (2 weeks) after end of study (16 weeks post start) ]
    Feedback on perceptions of the mobile app and information on continued use behaviors



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Minimum age of 18 years
  • Enrolled in Consuming Happiness course during the Spring 2017-18 semester.
  • Must have access to WiFi, cellular service or computer with internet connection and web browser.

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03378505


Locations
Layout table for location information
United States, Wisconsin
School of Human Ecology
Madison, Wisconsin, United States, 53704
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Layout table for investigator information
Principal Investigator: Charles Raison, MD University of Wisconsin, Madison
Layout table for additonal information
Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT03378505    
Other Study ID Numbers: 2017-1371
A271000 ( Other Identifier: UW Madison )
SOHE\CONSUMER SCIENCE\CONS SCI ( Other Identifier: UW Madison )
First Posted: December 19, 2017    Key Record Dates
Last Update Posted: December 6, 2019
Last Verified: December 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: IDP will not be shared with researchers not directly associated with the study and/or listed on the IRB.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No